Replies to post #266570 on Anavex Life Sciences Corp (AVXL)

[bennyboy1]

TTT: Great find, as usual. At least we now know that H L Pharma in Australia is supplying 2-73 for Alzheimer's and Rett. It is now obvious that Anavex has chosen to provide 2-73, but I hope we can now find out what are they charging price-wise for those not in the Trials?

[JWC3]

Nice find, thanks TTTav66! How do you find all these obscure references. Nice!

[RedShoulder]

Australian specialist pharmaceutical wholesaler and distributor, HL Pharma, announced this past week:
Quote:
Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations.

https://www.anavex.com/anavex-life-sciences-receives-tga-special-access-scheme-approval-for-anavex2-73-blarcamesine-for-alzheimers-disease-patients/

https://www.9news.com.au/national/rett-syndrome-alzheimers-drug-medical-testing-underway-on-girls-sydney/c28040fa-31e9-45fd-89d3-d180b3a4ff24
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to ageing populations (Parkinson’s Disease and Alzheimer’s Disease)

https://hlpharma.com.au/anavex-life-sciences-and-hl-pharma/

Very interesting find TTT, a connecting dot, Looking at that 3rd link things are moving forward at a very nice pace indeed.

A big dot in connecting the logistics from drug mfg to patient.

3rd link:
"Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations."

[vg_future]

Excellent find TTTav66! Interesting mention about RETT in there. So, we are getting another NEWS piece soon........yay! Excited!

vg_future

[Gernee20]

Great find, thanks for posting TTT!

[Warby 3]

Thank you for sharing this Information gem


Best of luck to everyone here

[georgejjl]

TTT, Thanks for the great news

Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations.

https://www.anavex.com/anavex-life-sciences-receives-tga-special-access-scheme-approval-for-anavex2-73-blarcamesine-for-alzheimers-disease-patients/

https://www.9news.com.au/national/rett-syndrome-alzheimers-drug-medical-testing-underway-on-girls-sydney/c28040fa-31e9-45fd-89d3-d180b3a4ff24
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to ageing populations (Parkinson’s Disease and Alzheimer’s Disease)

https://hlpharma.com.au/anavex-life-sciences-and-hl-pharma/

Good luck and GOD bless,

[georgejjl]

HL Pharma has over 20 years of industry knowledge and experience sourcing and supplying unregistered/unlicensed pharmaceuticals to hospitals, pharmacies, doctors, veterinarians and pharmaceutical wholesalers to ensure healthcare providers have access to an appropriate overseas registered product in the event the Australian registered product is in short supply or unavailable. HL Pharma hold licenses to import Schedule 2 (pharmacy medicine), S3 (pharmacist only medicine), S4 (prescription medicine/animal prescription medicine) S8 (controlled drug) and S9 (prohibited substance) HL Pharma is the partner of choice for the distribution of a number of niche pharmaceutical products.

Matt Hayward established HL Pharma in March 2014, having moved back to Australia after many years working in the UK. Matt has worked in many areas of the pharmacy profession including community pharmacy, hospital pharmacy, manufacturing, wholesaling and veterinary. He has extensive experience in the area of unregistered/unlicensed medicines supply, having owned his own company in the UK before it’s acquisition by United Drug of Ireland.

https://hlpharma.com.au/about-us/

https://www.anavex.com/anavex-life-sciences-receives-tga-special-access-scheme-approval-for-anavex2-73-blarcamesine-for-alzheimers-disease-patients/

Good luck and GOD bless,

[Investor2014]

Thank you for this TTT.

HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

The bit highlighted above is what the SAS Cat B approval is clearly aimed at.

Could $AVXL suddenly appreciate by 200% on this news????

[vg_future]

TTTav66, the RETT comment in this NEWS is interesting....any thoughts....potential NEWS on the horizon?
I wish this NEWS got enough airtime last week itself. It would have kept some of the concerns off of this board and also would have helped the stock price.

TIA,
vg_future

[Turner2017]

Australian Domination!!!!!

[jimmy_mcyoloswag]

Nice! Excellent sleuthing TTT!

[plexrec]

TTT--"Australian specialist pharmaceutical "--once again you come up with that "scoop"--great find--one of the reasons I come to this board--to get info posted by folks like you that is hard to find--keep digging----much appreciated---long AVXL !!!!!!!!!

[McMagyar]

Thanks a triple T!

[Turner2017]

I wonder if and when Anavex will release a PR announcing this partnership?

[attilathehunt]

T3 - Great find! Thank you!

Interesting in that Rett is also mentioned!!

Is off label use okay with SAS or should we expect to hear about SAS for Rett in the coming days?

Now that the August options have expired we will most likely make a run for the next two weeks with or without news.

[baltimorebullet]

While this is certainly a dot in the right direction, isn't it really just an example of a company(HL Pharma) cashing in by opportunistically filling a need created by the creation of SAS?

[FitzyP33]

When you click the HL Pharma news link in this message I get a 404 error. I assume that means this was a fake web page all along and there is no distribution by HL Pharma.

[XenaLives]

A copy of the replied to post brom TTTav66:

Australian specialist pharmaceutical wholesaler and distributor, HL Pharma, announced this past week:
Quote:
Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations.

https://www.anavex.com/anavex-life-sciences-receives-tga-special-access-scheme-approval-for-anavex2-73-blarcamesine-for-alzheimers-disease-patients/

https://www.9news.com.au/national/rett-syndrome-alzheimers-drug-medical-testing-underway-on-girls-sydney/c28040fa-31e9-45fd-89d3-d180b3a4ff24
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to ageing populations (Parkinson’s Disease and Alzheimer’s Disease)

https://hlpharma.com.au/anavex-life-sciences-and-hl-pharma/

IMO this was taken down because it was premature.